1. Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy
2. Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy
3. Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy